Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-023302

Options or other derivatives

  • General Counsel acquired 36,549 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murdock Hunter R. General Counsel 2024-02-27 Grant or award · Employee Stock Option (Right to Buy) +23,593 23,593 D: show line 1 in the form
Murdock Hunter R. General Counsel 2024-02-27 Grant or award · Restricted Stock Units +12,956 12,956 D: show line 2 in the form
Loading xslF345X05/ownership.xml…